In This Guide
  1. Why a Catalyst Calendar Is Essential
  2. What Makes 2026 Different
  3. How to Use a Catalyst Calendar Effectively
  4. Beyond PDUFA: Other Catalysts Worth Tracking

Why a Catalyst Calendar Is Essential for Biotech Traders

Biotech stocks do not move like other sectors. While most stocks are driven by quarterly earnings, biotech companies live and die by binary catalysts: FDA decisions, clinical trial data readouts, and regulatory milestones that can change a company’s value by 50% or more overnight.

A catalyst calendar is the single most important tool in a biotech trader’s workflow. But most catalyst calendars treat every event equally. A PDUFA date for a blockbuster drug at large pharma is listed right alongside a micro-cap biotech with one shot at survival. These are not the same events.

What Makes 2026 Different

The 2026 FDA calendar is one of the busiest in recent years. The post-COVID application backlog is still working through the pipeline. The accelerated approval pathway has produced a wave of new submissions across oncology, rare disease, and gene therapy. The FDA’s increasing comfort with real-world evidence is opening doors for faster approvals. For traders, more catalysts means more opportunities — but also more noise.

How to Use a Catalyst Calendar Effectively

Start by filtering for event type. PDUFA dates and AdCom meetings are the highest-impact FDA events. Phase 3 data readouts are next. Phase 2 data produces smaller moves unless the stock is a micro-cap.

Next, filter by market capitalization. Micro-cap and small-cap biotechs produce the largest percentage moves because a single drug often represents the majority of the company’s value.

Then assess the setup. What is implied volatility telling you about expected move size? What is short interest? How much has the stock already moved into the catalyst? These market reality indicators transform a simple date into an actionable trade setup.

Beyond PDUFA: Other Catalysts Worth Tracking

Patent cliffs. Breakthrough Therapy designations and Fast Track grants. Conference presentations at ASCO, ASH, AAN, and EASL. Partnership and licensing deals. These are all tradeable events that get less attention than PDUFA dates but can produce significant moves.

Related Articles

Related
What Is a PDUFA Date?
The FDA deadline every biotech trader needs to know — and how it drives stock volatility.
Related
Biotech Market Cap Tiers Explained
Why market cap matters more than share price when evaluating biotech catalyst risk.

Stop scrolling through calendar lists.

See every 2026 biotech catalyst ranked by Bio-Score™ predicted volatility magnitude. Wall Street intelligence. Retail pricing.

See Ranked Catalysts →